Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients | Zendy

HerwigUlf MeierKriesche | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients

Author(s) -

HerwigUlf MeierKriesche

Publication year - 2004

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfh445

Subject(s) - medicine , azathioprine , mycophenolate , immunosuppression , kidney transplantation , population , renal transplant , mycophenolic acid , gastroenterology , transplantation , disease , environmental health

Mycophenolate mofetil (MMF) has been shown to decrease acute rejection episodes after kidney transplantation, and has been associated with better graft and patient survival vs azathioprine (AZA). Previous studies reported a higher risk of death due to infection in elderly recipients treated with MMF-based immunosuppression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research